Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

Completed

Conditions studied: Leukemia

In brief

RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors predict response in patients previously treated with interleukin-2. PURPOSE: This laboratory study is looking at the relationship between natural killer cells' ability to kill leukemia cells and the outcome of patients with acute myeloid leukemia previously treated with interleukin-2.

Key facts

Study ID

NCT00896701

Run by

Alliance for Clinical Trials in Oncology

People needed

451

Starts

2004-01-01

Expected to finish

2014-04-01

Last updated by the study team

2016-07-13

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Kinston Medical Specialists — Kinston, North Carolina, United States
• Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.